About Synergy Research Group
The Synergy Research Group (SRG) provides support to the pharmaceutical, biotechnology, and medical device industries with a comprehensive range of collaborative services and solutions. It specializes in cardiovascular trials, patient recruitment, risk-based monitoring, and more. It was founded in 2002 and is based in Moscow, Russian Fédération.
Missing: Synergy Research Group's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Synergy Research Group's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Synergy Research Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Synergy Research Group in 1 CB Insights research brief, most recently on Dec 20, 2022.
Latest Synergy Research Group News
Oct 5, 2022
Share Listed engineering services business SRG Global is jockeying for investor attention just as Thiess gets ready to take MACA off the ASX boards. Street Talk. Bloomberg SRG Global’s teed up a non-deal roadshow for this week via Shaw and Partners, looking to get some face-time with Sydney fund managers just as MACA looks like its being snapped up. Street Talk understands Shaws had lined up about eight meetings for SRG’s executives while they are in town for less exciting, everyday business. Investors are only too happy to hear from listed engineering services businesses. They are among the rare sectors in green this year, but tragically, also in short supply on the ASX boards. However, fundies know all too well that a non-deal roadshow is often just the warm-up session to something - a raising and/or some M&A. Advertisement In SRG Global’s case, investors reckon there’s no way it needs to raise for everyday operations. It was already up to $646.5 million revenue for the 2022 financial year, and has been winning contracts left, right and centre for its offering in asset maintenance, engineering and construction, and mining. The balance sheet had $59.3 million cash at June 30, a healthy amount for a company $309 million market capitalisation. And so, investors reckon there’s the odd chance that SRG’s found something it likes enough to buy, or its just putting itself on shareholders’ radars. The latter’s likely the right reason. SRG’s growing strongly and has contracts with blue-chip clients, but it is also sparsely traded and a long-way off the multiples that its bigger comparable Monadelphous trades at. Anthony Macdonald co-edits Street Talk, specialising in private equity, investment banking, M&A and equity capital markets. He has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter . Email Anthony at email@example.com Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at firstname.lastname@example.org Kanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at email@example.com Save
Synergy Research Group Frequently Asked Questions (FAQ)
Where is Synergy Research Group's headquarters?
Synergy Research Group's headquarters is located at 11, 4-Magistralnaya Str.,, Moscow.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.